← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 1989Last known activity
Oct 1, 2011
Timeline
1950s
- Jan 1, 1956
Cancer and Leukemia Group B (CALGB)— Founded
Drugs by trial phase (108 distinct, 120 trials)
Phase 3 (82 own, 0 via acquisition)
Phase 2 (25 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Mucinous
- Adenocarcinoma of Lung
- Amyloidosis
- Anus Neoplasms
- Astrocytoma
- Basal Cell Carcinoma
- Breast Neoplasms
- Breast Neoplasms, Male
- Burkitt Lymphoma
- Carcinoma
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma in Situ
- Carcinoma, Mucoepidermoid
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinoma, Verrucous
- Cardiotoxicity
- Colonic Neoplasms
- Colorectal Neoplasms
- Cystadenocarcinoma
- Diarrhea
- Dysgerminoma
- Endometrial Neoplasms
- Ependymoma
- Esophageal Neoplasms
- Esthesioneuroblastoma, Olfactory
- Fatigue
- Germinoma
- Glioblastoma
- Glioma
- Glioma, Subependymal
- Gliosarcoma
- Granuloma
- Head and Neck Neoplasms
- Hodgkin Disease
- Hypereosinophilic Syndrome
- Immunoblastic Lymphadenopathy
- Immunoglobulin Light-chain Amyloidosis
- Infertility
- Inflammatory Breast Neoplasms
- Kidney Neoplasms
- Laryngeal Diseases
- Laryngeal Neoplasms
- Leukemia
- Leukemia, Basophilic, Acute
- Leukemia, Eosinophilic, Acute
- Leukemia, Erythroblastic, Acute
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, Megakaryoblastic, Acute
- Leukemia, Monocytic, Acute
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Promyelocytic, Acute
- Leukemia, T-Cell
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Lymphomatoid Granulomatosis
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Mycoses
- Mycosis Fungoides
- Myelodysplastic Syndromes
- Nasopharyngeal Carcinoma
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Plasma Cell
- Neoplasms, Unknown Primary
- Neuroectodermal Tumors, Primitive
- Neurotoxicity Syndromes
- Oligodendroglioma
- Oropharyngeal Neoplasms
- Ovarian Neoplasms
- Pancoast Syndrome
- Pancreatic Neoplasms
- Papilloma
Recent trials (50)
- NCT01478477CollaboratorN/AOct 1, 2011
- NCT01311336CollaboratorPhase 2May 1, 2011
- NCT01279681CollaboratorPhase 3Jan 1, 2011
- NCT00433511CollaboratorPhase 3Dec 1, 2009
- NCT00738881CollaboratorPhase 3Oct 1, 2008
- NCT00742625Overall official - principal investigatorPhase 1/Phase 2Sep 1, 2008
- NCT00567580CollaboratorPhase 3Feb 1, 2008
- NCT00554463CollaboratorPhase 2Jan 1, 2008
- NCT00659373Study chairPhase 3Dec 1, 2007
- NCT00659373CollaboratorPhase 3Dec 1, 2007
- NCT00533949CollaboratorPhase 3Nov 1, 2007
- NCT00499369CollaboratorPhase 3Jun 1, 2007
- NCT00324805CollaboratorPhase 3Jun 1, 2007
- NCT00470054Overall official - principal investigatorPhase 2Apr 1, 2007
- NCT00453154Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2007
Details
- Founded
- Chicago, IL, US Jan 1, 1956
- Last known activity
- Oct 1, 2011